Arax Advisory Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$977 Buy
198
+140
+241% +$751 ﹤0.01% 4938
2026
Q1
$313 Buy
58
+30
+107% +$180 ﹤0.01% 3484
2025
Q4
$195 Buy
+28
New +$184 ﹤0.01% 3727
2022
Q3
Sell
-175
Closed -$1K 1210
2022
Q2
$1K Buy
175
+25
+17% +$349 ﹤0.01% 1011
2022
Q1
$3K Buy
+150
New +$3.67K ﹤0.01% 863

Other funds holding BHC

Arax Advisory Partners's BHC Position: Q2 2026 in Review

Arax Advisory Partners increased its Bausch Health (BHC) stake by 241% in Q2 2026, buying an estimated $751 and bringing the position to 198 shares worth $977. The position accounts for ﹤0.01% of the portfolio, ranked #4938.

Arax Advisory Partners first reported a position in BHC in Q1 2022 and has held it in 5 quarters since. The position peaked at $3K in Q1 2022. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Arax Advisory Partners held 198 shares of Bausch Health worth $977 as of Q2 2026.
  • Arax Advisory Partners bought 140 Bausch Health shares in Q2 2026, an estimated $751.
  • Bausch Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4938 holding.
  • Arax Advisory Partners first reported a position in Bausch Health in Q1 2022 and has held it in 5 quarters since.
  • Arax Advisory Partners's Bausch Health position peaked at $3K in Q1 2022.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.